Therefore, our in vivo results indicate that not only does ARG1 activation augment the malignancy of colon cancer cells but also it modulates the tumor microenvironment involved in the dysfunction of host immunity, which facilitates the metastatic colonization of colon cancer cells in the liver. Here, ARG1 is linked to colonic neoplasm.